Senior Director, Research Strategy and Operations (Core Team Leader)
Tempus AI
Summary
Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time. We are seeking an industry veteran to serve as the Core Team Leader (CTL) to support our growing product portfolio.
Job description
In this high-impact role, you will act as the "Leader of the Product Development Lifecycle." You will move beyond simple project coordination to assume full accountability for the execution and commercial launch of complex regulated diagnostic products. You will lead a cross-functional Core Team - comprising leaders from R&D, Clinical, Regulatory, Quality, Software, and Operations - to navigate the journey from concept to commercialization. This is a matrix leadership role. You will partner with a Product Manager (who defines market strategy) and a Project Manager (who manages tactical schedules), while you provide the strategic glue, operational oversight, and decision-making authority required to deliver the product to market.
Key Responsibilities
Cross-Functional Leadership & Accountability
- Serve as the single point of accountability for the development lifecycle, ensuring the team delivers against the Target Product Profile (TPP) and Product Requirements against a defined timeline.
- Lead a dedicated Core Team of functional heads (Science, Engineering, Quality, Regulatory, Lab Ops) without direct line authority.
- Effectively negotiate priorities, drive consensus among peers with competing incentives, and align disparate groups toward a shared vision.
- Ensure the technical and clinical vision defined at the start of the project is consistently understood and executed across all technical sub-teams, preventing scope creep or strategic drift.
- Proactively identify and resolve friction between functional groups (e.g., Commercial timelines vs. R&D feasibility).
- Serve as the primary mediator, fostering constructive debate to reach rapid, data-driven decisions without needing constant escalation.
Stage-Gate Governance & Strategic Execution
- Lead the product team through formal Stage-Gate Reviews (Phase Exits).
- Synthesize complex technical, clinical, and operational data into clear, actionable business narratives for the leadership team.
- Proactively identify critical path risks and drive difficult trade-off decisions between scope, timeline, and resources.
- Collaborate with functional leadership to ensure appropriate resource allocation, ensuring the project aligns with the broader Tempus portfolio priorities.
Design Control & Operational Scale
- Champion a development process compliant with Design Control (21 CFR 820) and ISO 13485 standards.
- Guide the team through the rigors of LDT, 510(k), or PMA regulatory pathways.
- Oversee the critical transition from R&D to Clinical Lab Operations, ensuring the "order-to-result" workflow is robust, scalable, and ready for commercial volume prior to launch.
- Act as the primary link between technical development and the Commercial organization, ensuring that technical milestones translate into market-ready value propositions.
Qualifications
- Advanced degree (PhD, MD, MS) in Genetics, Molecular Biology, or Engineering required.
- MBA is a strong plus.
- 10+ years in the life sciences/diagnostics industry, with at least 4+ years serving as a Core Team Leader, Product Development Lead, or Program Director in a matrixed environment.
- Deep experience in Oncology Diagnostics, NGS, or Liquid Biopsy is essential.
- Experience navigating FDA Class II/III medical device development (PMA/510k) is highly preferred.
Competencies
- Expert knowledge of Phased-Gate/Stage-Gate development cycles.
- High emotional intelligence and communication skills required to manage up to executive level stakeholders.
- Demonstrated ability to influence without authority.
- Ability to "speak the language" of both the R&D scientists developing the chemistry and the Commercial leaders selling the test.
- Focus on the manufacturability and operational scalability of the test.
Key Success Metrics
- Efficiency and success rate of Stage-Gate (Phase Exit) presentations to the Executive Committee.
- Adherence to the roadmap timeline while ensuring Design Control compliance.
- Seamless transfer to Operations with met KPIs for Turnaround Time (TAT) and success rates upon launch.
- High engagement and clarity scores from cross-functional Core Team members.
At Tempus AI, we believe the future of medicine lies at the intersection of science and data. In this role, you will be at the center of that evolution, transforming how liquid biopsy and xF diagnostics provide clarity to clinicians and better outcomes for patients.
Requirements
- Advanced degree (PhD, MD, MS) in Genetics, Molecular Biology, or Engineering
- 10+ years in the life sciences/diagnostics industry
- At least 4+ years as a Core Team Leader, Product Development Lead, or Program Director in a matrixed environment
- Deep experience in Oncology Diagnostics, NGS, or Liquid Biopsy
- Expert knowledge of Phased-Gate/Stage-Gate development cycles
- High emotional intelligence and communication skills to manage executive-level stakeholders
- Demonstrated ability to influence without authority
- Ability to communicate across R&D and Commercial functions
- MBA is a strong plus
- Experience navigating FDA Class II/III medical device development (PMA/510k) is highly preferred
Benefits
- Incentive Compensation
- Restricted Stock Units
- Medical Benefits
Company overview
Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.